Keyphrases
Phase II Study
100%
Metastatic Colorectal Cancer (mCRC)
100%
CPT-11
100%
Irinotecan
100%
Oxaliplatin
100%
5-fluorouracil (5-FU)
100%
Leucovorin
100%
Overall Survival
25%
Kidney Function
25%
Dose Level
25%
Maximum Tolerated Dose
25%
Metastatic Disease
25%
Liver Function
25%
Multicenter Trial
25%
Liver Metastasis
25%
Recommended Dose
25%
Neurologic
25%
Diarrhea
25%
Before Surgery
25%
High Efficacy
25%
Performance Status
25%
Palliative Chemotherapy
25%
Time to Progression
25%
Neutropenia
25%
Partial Response
25%
Tumor Control
25%
Febrile Neutropenia
25%
Median Time
25%
Dose-limiting Toxicity
25%
Measurable Disease
25%
Colorectal Cancer Patients
25%
Metastases Resection
25%
Medicine and Dentistry
Fluorouracil
100%
Irinotecan
100%
Oxaliplatin
100%
Metastatic Colorectal Cancer
100%
Folinic Acid
100%
Neoplasm
25%
Overall Survival
25%
Neutropenia
25%
Infusion
25%
Liver Metastasis
25%
Metastatic Carcinoma
25%
Febrile Neutropenia
25%
Liver Function
25%
Diarrhea
25%
Metastasectomy
25%
Kidney Function
25%
Colorectal Carcinoma
25%
Recommended Drug Dose
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Irinotecan
100%
Metastatic Colorectal Cancer
100%
Oxaliplatin
100%
Fluorouracil
100%
Folinic Acid
100%
Chemotherapy
25%
Overall Survival
25%
Liver Metastasis
25%
Diarrhea
25%
Colorectal Carcinoma
25%
Neoplasm
25%
Maximum Tolerated Dose
25%
Neutropenia
25%
Febrile Neutropenia
25%
Diseases
25%